Recap: Protalix BioTherapeutics Q4 Earnings

Protalix BioTherapeutics PLX reported its Q4 earnings results on Thursday, March 31, 2022 at 06:50 AM.

Here's what investors need to know about the announcement.

Earnings

Protalix BioTherapeutics missed estimated earnings by 27.27%, reporting an EPS of $-0.14 versus an estimate of $-0.11.

Revenue was down $10.95 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 4.35% drop in the share price the next day.

Here's a look at Protalix BioTherapeutics's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.